Brain receptor methodologies. Part B, Amino acids, peptides, psychoactive drugs. / edited by Paul J. Marangos, Iain C. Campbell, Robert M. Cohen. [electronic resource]

Externí odkaz: Kolekce e-knih KNAV Registrovani uzivatele: plny text online 5 minut, dalsi pristup na vyzadani. Registered users: full text online 5 minutes, further access on request.

Development and Evaluation in Rat and Monkey of a Candidate Homochiral Radioligand for PET Studies of Brain Receptor Interacting Protein Kinase 1: [ ¹⁸ F]( S )-1-(5-(3-Fluorophenyl)-4,5-dihydro-1 H -pyrazol-1-yl)-2,2-dimethylpropan-1-one.

Autor: Jana S; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Maqbool M; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Yan X; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Jakobsson JE; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Lee AC; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Liow JS; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Zoghbi SS; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Wu S; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Long P; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Innis RB; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Telu S; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States., Pike VW; Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, United States.

Publikováno v: ACS chemical neuroscience [ACS Chem Neurosci] 2025 Jan 02. Date of Electronic Publication: 2025 Jan 02.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations

Autor: Laura Oggianu, Giorgio Di Dato, Giorgina Mangano, Maria Teresa Rosignoli, Savannah McFeely, Alice Ban Ke, Hannah M. Jones, Alessandro Comandini

Publikováno v: Clinical and Translational Science, Vol 15, Iss 6, Pp 1417-1429 (2022)

Abstract Trazodone is approved for the treatment of major depressive disorders, marketed as immediate release (IR), prolonged release, and once a day (OAD) formulation. The different formulations allow different administration schedules and may be us

Externí odkaz: https://doaj.org/article/d9d926ebb4ce4587b933ee559be1a693

Influence of Piracetam on Brain Receptor Systems in CD-1 Mice with Different Attention Stability Phenotypes

Autor: G. I. Kovalev, R. M. Salimov, N. A. Sukhorukova, E. V. Vasil’eva, E. A. Kondrakhin

Publikováno v: Pharmaceutical Chemistry Journal. 55:757-761

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9350f614884c5fa27f3c655fd93473db
https://doi.org/10.1007/s11094-021-02489-8